These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 21057388

  • 1. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
    Cai J, Terasaki PI.
    Transplantation; 2010 Dec 27; 90(12):1511-5. PubMed ID: 21057388
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
    Lentine KL, Schnitzler MA, Xiao H, Brennan DC.
    Trials; 2015 Aug 19; 16():365. PubMed ID: 26285695
    [Abstract] [Full Text] [Related]

  • 4. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.
    Transplant Proc; 2011 Mar 19; 43(2):458-61. PubMed ID: 21440733
    [Abstract] [Full Text] [Related]

  • 5. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.
    Deeks ED, Keating GM.
    Drugs; 2009 Jul 30; 69(11):1483-512. PubMed ID: 19634926
    [Abstract] [Full Text] [Related]

  • 6. Antibody induction therapy for lung transplant recipients.
    Penninga L, Møller CH, Penninga EI, Iversen M, Gluud C, Steinbrüchel DA.
    Cochrane Database Syst Rev; 2013 Nov 27; 2013(11):CD008927. PubMed ID: 24282128
    [Abstract] [Full Text] [Related]

  • 7. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA, Kilic A, Lehman A, Wehr A, Hasan A, Haas G, Hayes D, Sai-Sudhakar CB, Higgins RS.
    Clin Transplant; 2015 Jan 27; 29(1):9-17. PubMed ID: 25284138
    [Abstract] [Full Text] [Related]

  • 8. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.
    Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP.
    J Am Soc Nephrol; 2017 Jul 27; 28(7):2188-2200. PubMed ID: 28320767
    [Abstract] [Full Text] [Related]

  • 9. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid.
    Uemura T, Schaefer E, Hollenbeak CS, Khan A, Kadry Z.
    Transpl Int; 2011 Jul 27; 24(7):640-50. PubMed ID: 21429047
    [Abstract] [Full Text] [Related]

  • 10. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM, Keating GM.
    Drugs; 2003 Jul 27; 63(24):2803-35. PubMed ID: 14664658
    [Abstract] [Full Text] [Related]

  • 11. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G, Somma C, Gennarini A, Mastroluca D, Rota G, Lacanna F, Locatelli B, Remuzzi G, Ruggenenti P.
    Am J Nephrol; 2015 Jul 27; 41(1):16-27. PubMed ID: 25612603
    [Abstract] [Full Text] [Related]

  • 12. Induction therapy in renal transplant recipients: how convincing is the current evidence?
    Wagner SJ, Brennan DC.
    Drugs; 2012 Mar 26; 72(5):671-83. PubMed ID: 22439670
    [Abstract] [Full Text] [Related]

  • 13. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE, Weng RR, Piper M, Laugenou K, Ichii H, Lakey J, Malinoski D.
    Transplant Proc; 2012 Jan 26; 44(1):164-6. PubMed ID: 22310605
    [Abstract] [Full Text] [Related]

  • 14. Does Induction Type Influence Outcomes in Kidney Transplant Recipients at Different Phases of Hepatitis B Infection?
    Sureshkumar KK, Chopra B.
    Exp Clin Transplant; 2019 Aug 26; 17(4):457-460. PubMed ID: 30066624
    [Abstract] [Full Text] [Related]

  • 15. Steroid maintenance in repeat kidney transplantation: influence of induction agents on outcomes.
    Sureshkumar KK, Hussain SM, Nashar K, Marcus RJ.
    Saudi J Kidney Dis Transpl; 2014 Jul 26; 25(4):741-9. PubMed ID: 24969182
    [Abstract] [Full Text] [Related]

  • 16. Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.
    Heifets M, Saeed MI, Parikh MH, Sierka D, Kumar MS.
    Drugs Aging; 2004 Jul 26; 21(11):747-56. PubMed ID: 15323580
    [Abstract] [Full Text] [Related]

  • 17. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
    Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD.
    Ann Surg; 2014 May 26; 259(5):888-93. PubMed ID: 24513787
    [Abstract] [Full Text] [Related]

  • 18. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.
    Expert Opin Biol Ther; 2014 Dec 26; 14(12):1723-30. PubMed ID: 25156622
    [Abstract] [Full Text] [Related]

  • 19. A contemporary analysis of induction immunosuppression in pediatric lung transplant recipients.
    Hayes D, Kirkby S, Wehr AM, Lehman AM, McConnell PI, Galantowicz M, Higgins RS, Whitson BA.
    Transpl Int; 2014 Feb 26; 27(2):211-8. PubMed ID: 24236829
    [Abstract] [Full Text] [Related]

  • 20. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F, Zieroth S, Rao V, Ross H, Delgado DH.
    J Heart Lung Transplant; 2006 Nov 26; 25(11):1358-62. PubMed ID: 17097501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.